

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 7.46904695 |
| 2 | actin-myosin filament sliding (GO:0033275) | 7.46904695 |
| 3 | cytidine catabolic process (GO:0006216) | 7.03052546 |
| 4 | cytidine deamination (GO:0009972) | 7.03052546 |
| 5 | cytidine metabolic process (GO:0046087) | 7.03052546 |
| 6 | response to muscle activity (GO:0014850) | 6.60632413 |
| 7 | sarcomere organization (GO:0045214) | 6.54657452 |
| 8 | skeletal muscle fiber development (GO:0048741) | 6.53087040 |
| 9 | actin-mediated cell contraction (GO:0070252) | 6.19870943 |
| 10 | cardiac myofibril assembly (GO:0055003) | 6.10927945 |
| 11 | myofibril assembly (GO:0030239) | 5.97099425 |
| 12 | myotube cell development (GO:0014904) | 5.96488526 |
| 13 | axon ensheathment in central nervous system (GO:0032291) | 5.77235569 |
| 14 | central nervous system myelination (GO:0022010) | 5.77235569 |
| 15 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.68855476 |
| 16 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.48814436 |
| 17 | skeletal muscle adaptation (GO:0043501) | 5.31364901 |
| 18 | B cell receptor signaling pathway (GO:0050853) | 5.14505530 |
| 19 | muscle fiber development (GO:0048747) | 5.13965648 |
| 20 | regulation of skeletal muscle contraction (GO:0014819) | 5.11614169 |
| 21 | negative regulation of protein localization to cell surface (GO:2000009) | 5.01775062 |
| 22 | regulation of relaxation of muscle (GO:1901077) | 5.01512003 |
| 23 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.98839603 |
| 24 | cardiac muscle contraction (GO:0060048) | 4.94426554 |
| 25 | actin filament-based movement (GO:0030048) | 4.86704251 |
| 26 | striated muscle atrophy (GO:0014891) | 4.83529439 |
| 27 | creatine metabolic process (GO:0006600) | 4.82352009 |
| 28 | striated muscle contraction (GO:0006941) | 4.66898793 |
| 29 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.61602917 |
| 30 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.52875452 |
| 31 | adult heart development (GO:0007512) | 4.49518884 |
| 32 | * skeletal muscle tissue development (GO:0007519) | 4.41333999 |
| 33 | striated muscle adaptation (GO:0014888) | 4.40811651 |
| 34 | regulation of cell communication by electrical coupling (GO:0010649) | 4.40086764 |
| 35 | skeletal muscle contraction (GO:0003009) | 4.37204341 |
| 36 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.35386643 |
| 37 | muscle cell fate commitment (GO:0042693) | 4.34462681 |
| 38 | actomyosin structure organization (GO:0031032) | 4.34388345 |
| 39 | myelination (GO:0042552) | 4.32445170 |
| 40 | ensheathment of neurons (GO:0007272) | 4.32428604 |
| 41 | axon ensheathment (GO:0008366) | 4.32428604 |
| 42 | glycogen catabolic process (GO:0005980) | 4.32265000 |
| 43 | muscle atrophy (GO:0014889) | 4.29727369 |
| 44 | positive regulation of myotube differentiation (GO:0010831) | 4.25616559 |
| 45 | regulation of actin filament-based movement (GO:1903115) | 4.21400277 |
| 46 | muscle cell cellular homeostasis (GO:0046716) | 4.18775461 |
| 47 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.16055336 |
| 48 | regulation of sarcomere organization (GO:0060297) | 4.15949475 |
| 49 | skeletal muscle tissue regeneration (GO:0043403) | 4.14208045 |
| 50 | muscle organ development (GO:0007517) | 4.11177094 |
| 51 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.10971635 |
| 52 | muscle structure development (GO:0061061) | 4.09047003 |
| 53 | muscle tissue morphogenesis (GO:0060415) | 4.08987271 |
| 54 | glucan catabolic process (GO:0009251) | 3.99673802 |
| 55 | cardiac muscle cell development (GO:0055013) | 3.98397514 |
| 56 | glucan biosynthetic process (GO:0009250) | 3.97301300 |
| 57 | glycogen biosynthetic process (GO:0005978) | 3.97301300 |
| 58 | striated muscle cell development (GO:0055002) | 3.97146923 |
| 59 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.91191778 |
| 60 | cardiac muscle hypertrophy (GO:0003300) | 3.90772830 |
| 61 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.87171053 |
| 62 | regulation of striated muscle contraction (GO:0006942) | 3.86439095 |
| 63 | neuromuscular synaptic transmission (GO:0007274) | 3.82226512 |
| 64 | fatty acid elongation (GO:0030497) | 3.80460536 |
| 65 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.76028617 |
| 66 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.75960221 |
| 67 | neuronal action potential propagation (GO:0019227) | 3.75665665 |
| 68 | striated muscle hypertrophy (GO:0014897) | 3.74343987 |
| 69 | cellular response to zinc ion (GO:0071294) | 3.71965562 |
| 70 | cellular polysaccharide catabolic process (GO:0044247) | 3.70512845 |
| 71 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.69107089 |
| 72 | cardiac cell development (GO:0055006) | 3.65948346 |
| 73 | plasma membrane repair (GO:0001778) | 3.59579334 |
| 74 | response to inactivity (GO:0014854) | 3.58920295 |
| 75 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.58856109 |
| 76 | myoblast fusion (GO:0007520) | 3.54995691 |
| 77 | muscle adaptation (GO:0043500) | 3.53651651 |
| 78 | cellular response to epinephrine stimulus (GO:0071872) | 3.53307229 |
| 79 | positive regulation of myoblast differentiation (GO:0045663) | 3.52629600 |
| 80 | heart process (GO:0003015) | 3.51734745 |
| 81 | heart contraction (GO:0060047) | 3.51734745 |
| 82 | response to activity (GO:0014823) | 3.50531422 |
| 83 | response to epinephrine (GO:0071871) | 3.47769949 |
| 84 | regulation of cardioblast differentiation (GO:0051890) | 3.46627324 |
| 85 | ATP synthesis coupled proton transport (GO:0015986) | 3.46448460 |
| 86 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.46448460 |
| 87 | 2-oxoglutarate metabolic process (GO:0006103) | 3.43855098 |
| 88 | muscle cell development (GO:0055001) | 3.39635732 |
| 89 | polysaccharide catabolic process (GO:0000272) | 3.34214350 |
| 90 | myotube differentiation (GO:0014902) | 3.30465332 |
| 91 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.30014449 |
| 92 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.30014449 |
| 93 | muscle organ morphogenesis (GO:0048644) | 3.29860253 |
| 94 | regulation of muscle system process (GO:0090257) | 3.29678958 |
| 95 | carnitine shuttle (GO:0006853) | 3.28836261 |
| 96 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.27735544 |
| 97 | heart trabecula formation (GO:0060347) | 3.27328001 |
| 98 | regulation of the force of heart contraction (GO:0002026) | 3.24823710 |
| 99 | muscle hypertrophy (GO:0014896) | 3.24777666 |
| 100 | regulation of muscle contraction (GO:0006937) | 3.22627967 |
| 101 | NADH metabolic process (GO:0006734) | 3.22174900 |
| 102 | ubiquinone biosynthetic process (GO:0006744) | 3.18857048 |
| 103 | synaptic transmission, cholinergic (GO:0007271) | 3.16725950 |
| 104 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.16250039 |
| 105 | substantia nigra development (GO:0021762) | 3.15550505 |
| 106 | * striated muscle tissue development (GO:0014706) | 3.15065290 |
| 107 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.11754647 |
| 108 | muscle contraction (GO:0006936) | 3.11443148 |
| 109 | regulation of myoblast differentiation (GO:0045661) | 3.11334539 |
| 110 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.10934824 |
| 111 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.10296223 |
| 112 | respiratory electron transport chain (GO:0022904) | 3.10110899 |
| 113 | activated T cell proliferation (GO:0050798) | 3.09235660 |
| 114 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.09065194 |
| 115 | regulation of ATPase activity (GO:0043462) | 3.08200494 |
| 116 | regulation of ATP catabolic process (GO:1903289) | 3.08200494 |
| 117 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.05697033 |
| 118 | muscle hypertrophy in response to stress (GO:0003299) | 3.05624949 |
| 119 | cardiac muscle adaptation (GO:0014887) | 3.05624949 |
| 120 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.05624949 |
| 121 | negative regulation of potassium ion transport (GO:0043267) | 3.05428012 |
| 122 | response to redox state (GO:0051775) | 3.05225593 |
| 123 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.04578451 |
| 124 | tricarboxylic acid cycle (GO:0006099) | 3.03503370 |
| 125 | regulation of membrane repolarization (GO:0060306) | 3.03018927 |
| 126 | L-amino acid import (GO:0043092) | 3.02593635 |
| 127 | electron transport chain (GO:0022900) | 2.99109160 |
| 128 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.97902165 |
| 129 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.97902165 |
| 130 | regulation of collateral sprouting (GO:0048670) | 2.97525209 |
| 131 | regulation of action potential (GO:0098900) | 2.96680034 |
| 132 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.96423760 |
| 133 | myelin maintenance (GO:0043217) | 2.94962174 |
| 134 | peripheral nervous system axon ensheathment (GO:0032292) | 2.93480718 |
| 135 | myelination in peripheral nervous system (GO:0022011) | 2.93480718 |
| 136 | locomotory exploration behavior (GO:0035641) | 2.92161407 |
| 137 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.88308061 |
| 138 | actin filament depolymerization (GO:0030042) | 2.87853314 |
| 139 | membrane tubulation (GO:0097320) | 2.86859689 |
| 140 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.83315068 |
| 141 | L-glutamate transport (GO:0015813) | 2.80630803 |
| 142 | muscle system process (GO:0003012) | 2.79656306 |
| 143 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.77282350 |
| 144 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.76840258 |
| 145 | eye photoreceptor cell differentiation (GO:0001754) | 2.71981587 |
| 146 | photoreceptor cell differentiation (GO:0046530) | 2.71981587 |
| 147 | regulation of cardiac muscle contraction (GO:0055117) | 2.70252749 |
| 148 | cellular response to catecholamine stimulus (GO:0071870) | 2.70012434 |
| 149 | cellular response to monoamine stimulus (GO:0071868) | 2.70012434 |
| 150 | B cell proliferation (GO:0042100) | 2.69056882 |
| 151 | acidic amino acid transport (GO:0015800) | 2.67923109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.99637362 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.68633576 |
| 3 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 3.62489211 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.34179126 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.17601088 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.00916719 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.87841111 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.68528646 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.46299344 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.39201650 |
| 11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.37612985 |
| 12 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.35516138 |
| 13 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.34153871 |
| 14 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.34153871 |
| 15 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.27600855 |
| 16 | VDR_22108803_ChIP-Seq_LS180_Human | 2.18459437 |
| 17 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.14545227 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.10743360 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.07883655 |
| 20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.05958971 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.01970224 |
| 22 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.93173966 |
| 23 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.92273191 |
| 24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.71556956 |
| 25 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.69378256 |
| 26 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.66116029 |
| 27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.63824252 |
| 28 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.63352918 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.61423088 |
| 30 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.60669182 |
| 31 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57516836 |
| 32 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54157978 |
| 33 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.51256270 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.50487723 |
| 35 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.49998108 |
| 36 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.49307322 |
| 37 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.46152707 |
| 38 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44993432 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43622708 |
| 40 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.42414206 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42224993 |
| 42 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40857986 |
| 43 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.40733694 |
| 44 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38071625 |
| 45 | SA1_27219007_Chip-Seq_Bcells_Human | 1.37413932 |
| 46 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.35266710 |
| 47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.33249187 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31650272 |
| 49 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.30385197 |
| 50 | P68_20966046_ChIP-Seq_HELA_Human | 1.29372349 |
| 51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27731977 |
| 52 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.27316590 |
| 53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25822551 |
| 54 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.25466663 |
| 55 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.24611922 |
| 56 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.24337916 |
| 57 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.24328220 |
| 58 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22915312 |
| 59 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22420309 |
| 60 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.20543489 |
| 61 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.20157479 |
| 62 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.20067767 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19822019 |
| 64 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.19370370 |
| 65 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19217572 |
| 66 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.18884064 |
| 67 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.18721281 |
| 68 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.18721281 |
| 69 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.18252798 |
| 70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17835760 |
| 71 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.17407776 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17255843 |
| 73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15968029 |
| 74 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.15769444 |
| 75 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.15403320 |
| 76 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.14515669 |
| 77 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.14423340 |
| 78 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.14342668 |
| 79 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.14289642 |
| 80 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.12436475 |
| 81 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12255219 |
| 82 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12066217 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11906905 |
| 84 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11892914 |
| 85 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11085587 |
| 86 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.10849458 |
| 87 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.10440368 |
| 88 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09695544 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09552878 |
| 90 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09307102 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08983110 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08195272 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06863200 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06670753 |
| 95 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05585837 |
| 96 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.05580435 |
| 97 | TBL1_22424771_ChIP-Seq_293T_Human | 1.05015777 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04954360 |
| 99 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04931445 |
| 100 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04846715 |
| 101 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.04372728 |
| 102 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.04035404 |
| 103 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03421455 |
| 104 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.03226479 |
| 105 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03136772 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03124597 |
| 107 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.02795716 |
| 108 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02448881 |
| 109 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.01709318 |
| 110 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.00284259 |
| 111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00176332 |
| 112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99918136 |
| 113 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99732575 |
| 114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98221037 |
| 115 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98052062 |
| 116 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97837666 |
| 117 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.97295027 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96908086 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96545278 |
| 120 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96401729 |
| 121 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.96392697 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96235685 |
| 123 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.95936003 |
| 124 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95901988 |
| 125 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95752589 |
| 126 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.95673863 |
| 127 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.95655349 |
| 128 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.94836846 |
| 129 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94520793 |
| 130 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.94303011 |
| 131 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.94021307 |
| 132 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.93807324 |
| 133 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93745784 |
| 134 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93656537 |
| 135 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92915082 |
| 136 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.92282373 |
| 137 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.92268764 |
| 138 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.91949403 |
| 139 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.91505286 |
| 140 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90926086 |
| 141 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.90912702 |
| 142 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.90846177 |
| 143 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.90254986 |
| 144 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90182690 |
| 145 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89655149 |
| 146 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.89243535 |
| 147 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.88962194 |
| 148 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.88763469 |
| 149 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.88762125 |
| 150 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.88509724 |
| 151 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.88007495 |
| 152 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.87279808 |
| 153 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.87256493 |
| 154 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87165440 |
| 155 | NFYB_21822215_ChIP-Seq_K562_Human | 0.87122794 |
| 156 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.87114818 |
| 157 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.86585843 |
| 158 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.86410817 |
| 159 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86364734 |
| 160 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86304085 |
| 161 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86075028 |
| 162 | STAT3_23295773_ChIP-Seq_U87_Human | 0.86050833 |
| 163 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.85904244 |
| 164 | NFYA_21822215_ChIP-Seq_K562_Human | 0.85709700 |
| 165 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.85060810 |
| 166 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.84934341 |
| 167 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.84732142 |
| 168 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.84436544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000749_muscle_degeneration | 4.61353955 |
| 2 | MP0000751_myopathy | 4.46412184 |
| 3 | MP0004036_abnormal_muscle_relaxation | 4.31961317 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 4.29345865 |
| 5 | MP0004084_abnormal_cardiac_muscle | 4.22123535 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 3.88233487 |
| 7 | MP0003646_muscle_fatigue | 3.80161672 |
| 8 | MP0005330_cardiomyopathy | 3.24169474 |
| 9 | MP0004215_abnormal_myocardial_fiber | 3.12731121 |
| 10 | MP0003950_abnormal_plasma_membrane | 3.04552752 |
| 11 | MP0000747_muscle_weakness | 2.83639720 |
| 12 | * MP0004087_abnormal_muscle_fiber | 2.82577333 |
| 13 | MP0000920_abnormal_myelination | 2.80020209 |
| 14 | MP0004510_myositis | 2.73378671 |
| 15 | MP0002106_abnormal_muscle_physiology | 2.65877433 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.46717309 |
| 17 | MP0002972_abnormal_cardiac_muscle | 2.39202740 |
| 18 | MP0002269_muscular_atrophy | 2.32991053 |
| 19 | MP0003137_abnormal_impulse_conducting | 2.22858465 |
| 20 | MP0005369_muscle_phenotype | 2.12341978 |
| 21 | * MP0000759_abnormal_skeletal_muscle | 2.07483402 |
| 22 | MP0010630_abnormal_cardiac_muscle | 2.03085312 |
| 23 | MP0008775_abnormal_heart_ventricle | 1.95841636 |
| 24 | MP0001790_abnormal_immune_system | 1.95149803 |
| 25 | MP0005387_immune_system_phenotype | 1.95149803 |
| 26 | MP0003690_abnormal_glial_cell | 1.88780748 |
| 27 | MP0001800_abnormal_humoral_immune | 1.85187093 |
| 28 | MP0000750_abnormal_muscle_regeneration | 1.83207398 |
| 29 | MP0004484_altered_response_of | 1.72737039 |
| 30 | MP0005385_cardiovascular_system_phenoty | 1.65312636 |
| 31 | MP0001544_abnormal_cardiovascular_syste | 1.65312636 |
| 32 | MP0004130_abnormal_muscle_cell | 1.63667013 |
| 33 | MP0004085_abnormal_heartbeat | 1.61638105 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.58479956 |
| 35 | MP0003828_pulmonary_edema | 1.53549303 |
| 36 | MP0006138_congestive_heart_failure | 1.49050249 |
| 37 | MP0001529_abnormal_vocalization | 1.43723858 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.38124525 |
| 39 | MP0005451_abnormal_body_composition | 1.37666920 |
| 40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.36431099 |
| 41 | MP0004233_abnormal_muscle_weight | 1.32812109 |
| 42 | MP0000733_abnormal_muscle_development | 1.28136380 |
| 43 | MP0002127_abnormal_cardiovascular_syste | 1.21180441 |
| 44 | MP0002332_abnormal_exercise_endurance | 1.20723494 |
| 45 | MP0003880_abnormal_central_pattern | 1.20266630 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.12562356 |
| 47 | MP0001986_abnormal_taste_sensitivity | 1.11014521 |
| 48 | MP0002272_abnormal_nervous_system | 1.10917355 |
| 49 | MP0004134_abnormal_chest_morphology | 1.05196263 |
| 50 | MP0000013_abnormal_adipose_tissue | 1.02382130 |
| 51 | MP0004270_analgesia | 1.02304004 |
| 52 | MP0004142_abnormal_muscle_tone | 1.01682541 |
| 53 | MP0004147_increased_porphyrin_level | 1.01515970 |
| 54 | MP0008569_lethality_at_weaning | 0.99400010 |
| 55 | MP0001905_abnormal_dopamine_level | 0.98055375 |
| 56 | MP0005171_absent_coat_pigmentation | 0.96948100 |
| 57 | MP0002064_seizures | 0.96132886 |
| 58 | MP0003634_abnormal_glial_cell | 0.95073992 |
| 59 | MP0000685_abnormal_immune_system | 0.94462327 |
| 60 | MP0004742_abnormal_vestibular_system | 0.94219543 |
| 61 | MP0004043_abnormal_pH_regulation | 0.93352400 |
| 62 | MP0005423_abnormal_somatic_nervous | 0.93154377 |
| 63 | MP0005000_abnormal_immune_tolerance | 0.90852681 |
| 64 | MP0001486_abnormal_startle_reflex | 0.90595321 |
| 65 | MP0003136_yellow_coat_color | 0.90267308 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 0.88331114 |
| 67 | MP0002971_abnormal_brown_adipose | 0.85598473 |
| 68 | MP0003879_abnormal_hair_cell | 0.84764044 |
| 69 | MP0002638_abnormal_pupillary_reflex | 0.82773424 |
| 70 | MP0005310_abnormal_salivary_gland | 0.82042629 |
| 71 | MP0002723_abnormal_immune_serum | 0.81384286 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 0.81244142 |
| 73 | MP0002933_joint_inflammation | 0.81081178 |
| 74 | MP0002108_abnormal_muscle_morphology | 0.80865688 |
| 75 | MP0000266_abnormal_heart_morphology | 0.78638657 |
| 76 | MP0009046_muscle_twitch | 0.78509524 |
| 77 | MP0002822_catalepsy | 0.78432132 |
| 78 | MP0002420_abnormal_adaptive_immunity | 0.78352704 |
| 79 | MP0002229_neurodegeneration | 0.77866572 |
| 80 | MP0005623_abnormal_meninges_morphology | 0.76606850 |
| 81 | MP0009780_abnormal_chondrocyte_physiolo | 0.76355703 |
| 82 | MP0005551_abnormal_eye_electrophysiolog | 0.74551442 |
| 83 | MP0003303_peritoneal_inflammation | 0.74273531 |
| 84 | MP0000372_irregular_coat_pigmentation | 0.74173618 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.72744384 |
| 86 | MP0000003_abnormal_adipose_tissue | 0.69979764 |
| 87 | MP0002734_abnormal_mechanical_nocicepti | 0.69553792 |
| 88 | MP0001819_abnormal_immune_cell | 0.69542871 |
| 89 | MP0002234_abnormal_pharynx_morphology | 0.69443236 |
| 90 | MP0006035_abnormal_mitochondrial_morpho | 0.68824900 |
| 91 | MP0002067_abnormal_sensory_capabilities | 0.67399919 |
| 92 | MP0009745_abnormal_behavioral_response | 0.66877940 |
| 93 | MP0005375_adipose_tissue_phenotype | 0.66277817 |
| 94 | MP0001440_abnormal_grooming_behavior | 0.63871892 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.63844179 |
| 96 | MP0004924_abnormal_behavior | 0.63536340 |
| 97 | MP0005386_behavior/neurological_phenoty | 0.63536340 |
| 98 | MP0005670_abnormal_white_adipose | 0.63120820 |
| 99 | MP0006276_abnormal_autonomic_nervous | 0.62291951 |
| 100 | MP0005671_abnormal_response_to | 0.61423156 |
| 101 | MP0005083_abnormal_biliary_tract | 0.61154377 |
| 102 | MP0003045_fibrosis | 0.61047427 |
| 103 | MP0000716_abnormal_immune_system | 0.60965984 |
| 104 | MP0001485_abnormal_pinna_reflex | 0.60759832 |
| 105 | MP0006072_abnormal_retinal_apoptosis | 0.60299920 |
| 106 | MP0001502_abnormal_circadian_rhythm | 0.59632024 |
| 107 | MP0000689_abnormal_spleen_morphology | 0.59238495 |
| 108 | MP0008874_decreased_physiological_sensi | 0.59149086 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.58599246 |
| 110 | MP0004885_abnormal_endolymph | 0.58584983 |
| 111 | MP0005409_darkened_coat_color | 0.58163285 |
| 112 | MP0001661_extended_life_span | 0.54771338 |
| 113 | MP0003632_abnormal_nervous_system | 0.54670804 |
| 114 | MP0005266_abnormal_metabolism | 0.54617532 |
| 115 | MP0002398_abnormal_bone_marrow | 0.54001795 |
| 116 | MP0001968_abnormal_touch/_nociception | 0.52855131 |
| 117 | MP0002066_abnormal_motor_capabilities/c | 0.52422553 |
| 118 | MP0003635_abnormal_synaptic_transmissio | 0.52283614 |
| 119 | MP0001299_abnormal_eye_distance/ | 0.49142866 |
| 120 | MP0002078_abnormal_glucose_homeostasis | 0.47482465 |
| 121 | MP0005332_abnormal_amino_acid | 0.46518568 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.45869519 |
| 123 | MP0002249_abnormal_larynx_morphology | 0.41698504 |
| 124 | MP0008872_abnormal_physiological_respon | 0.40031093 |
| 125 | MP0005535_abnormal_body_temperature | 0.39523112 |
| 126 | MP0005452_abnormal_adipose_tissue | 0.36416349 |
| 127 | MP0008875_abnormal_xenobiotic_pharmacok | 0.33202478 |
| 128 | MP0002114_abnormal_axial_skeleton | 0.32929547 |
| 129 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.32813233 |
| 130 | MP0001943_abnormal_respiration | 0.31946200 |
| 131 | MP0002735_abnormal_chemical_nociception | 0.31667010 |
| 132 | MP0001346_abnormal_lacrimal_gland | 0.31650033 |
| 133 | MP0005376_homeostasis/metabolism_phenot | 0.28191880 |
| 134 | MP0003948_abnormal_gas_homeostasis | 0.27837524 |
| 135 | MP0009250_abnormal_appendicular_skeleto | 0.27577302 |
| 136 | MP0001984_abnormal_olfaction | 0.27145361 |
| 137 | MP0005253_abnormal_eye_physiology | 0.26935680 |
| 138 | MP0001970_abnormal_pain_threshold | 0.26847947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 6.11151739 |
| 2 | Gastrointestinal stroma tumor (HP:0100723) | 6.08170897 |
| 3 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.95792955 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 5.87108287 |
| 5 | Ulnar deviation of the wrist (HP:0003049) | 5.66200461 |
| 6 | Sudden death (HP:0001699) | 5.58506998 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 5.46742421 |
| 8 | Muscle fiber inclusion bodies (HP:0100299) | 4.93408206 |
| 9 | Calcaneovalgus deformity (HP:0001848) | 4.86484667 |
| 10 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.80654993 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 4.78309760 |
| 12 | Agammaglobulinemia (HP:0004432) | 4.73108943 |
| 13 | Abnormality of the calf musculature (HP:0001430) | 4.60676607 |
| 14 | Muscle fiber splitting (HP:0003555) | 4.57897347 |
| 15 | Nemaline bodies (HP:0003798) | 4.49234187 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.44680029 |
| 17 | Deformed tarsal bones (HP:0008119) | 4.39260267 |
| 18 | Subaortic stenosis (HP:0001682) | 4.37588120 |
| 19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.37588120 |
| 20 | Absent phalangeal crease (HP:0006109) | 4.34497419 |
| 21 | Fetal akinesia sequence (HP:0001989) | 4.28434995 |
| 22 | Ventricular tachycardia (HP:0004756) | 4.21196459 |
| 23 | Type 1 muscle fiber predominance (HP:0003803) | 4.12864156 |
| 24 | Popliteal pterygium (HP:0009756) | 3.75636831 |
| 25 | Atrial fibrillation (HP:0005110) | 3.66267822 |
| 26 | Abnormal finger flexion creases (HP:0006143) | 3.59789301 |
| 27 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.56111774 |
| 28 | Round ear (HP:0100830) | 3.54922717 |
| 29 | Myoglobinuria (HP:0002913) | 3.52506063 |
| 30 | Difficulty running (HP:0009046) | 3.49675029 |
| 31 | Lipoatrophy (HP:0100578) | 3.39180207 |
| 32 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.32120202 |
| 33 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.32120202 |
| 34 | Primary atrial arrhythmia (HP:0001692) | 3.30981885 |
| 35 | Fatigable weakness (HP:0003473) | 3.19568845 |
| 36 | Abnormality of the neuromuscular junction (HP:0003398) | 3.19568845 |
| 37 | Supraventricular tachycardia (HP:0004755) | 3.14766325 |
| 38 | Supraventricular arrhythmia (HP:0005115) | 3.04913024 |
| 39 | Frequent falls (HP:0002359) | 3.04863003 |
| 40 | Recurrent sinusitis (HP:0011108) | 3.04583783 |
| 41 | Small epiphyses (HP:0010585) | 3.04307145 |
| 42 | Distal lower limb muscle weakness (HP:0009053) | 3.02238873 |
| 43 | Weak cry (HP:0001612) | 3.02144831 |
| 44 | Type 2 muscle fiber atrophy (HP:0003554) | 3.00043588 |
| 45 | Areflexia of lower limbs (HP:0002522) | 2.99414270 |
| 46 | Prolonged QT interval (HP:0001657) | 2.99286317 |
| 47 | Sensory axonal neuropathy (HP:0003390) | 2.98077129 |
| 48 | Dilated cardiomyopathy (HP:0001644) | 2.94746796 |
| 49 | Distal arthrogryposis (HP:0005684) | 2.93428998 |
| 50 | Rhabdomyolysis (HP:0003201) | 2.91400863 |
| 51 | Neck muscle weakness (HP:0000467) | 2.90013104 |
| 52 | Verrucae (HP:0200043) | 2.88969802 |
| 53 | Papilloma (HP:0012740) | 2.88969802 |
| 54 | Amniotic constriction ring (HP:0009775) | 2.82550135 |
| 55 | Abnormality of placental membranes (HP:0011409) | 2.82550135 |
| 56 | Scapular winging (HP:0003691) | 2.78858542 |
| 57 | Asymmetric septal hypertrophy (HP:0001670) | 2.78291643 |
| 58 | Syncope (HP:0001279) | 2.71910966 |
| 59 | Bulbar palsy (HP:0001283) | 2.70600581 |
| 60 | Abnormality of the calcaneus (HP:0008364) | 2.69490621 |
| 61 | Muscle fiber atrophy (HP:0100295) | 2.66448515 |
| 62 | Emphysema (HP:0002097) | 2.61607302 |
| 63 | Muscle stiffness (HP:0003552) | 2.60472510 |
| 64 | Myopathic facies (HP:0002058) | 2.60242399 |
| 65 | Hip contracture (HP:0003273) | 2.55303472 |
| 66 | Myotonia (HP:0002486) | 2.54028631 |
| 67 | Ventricular arrhythmia (HP:0004308) | 2.52392855 |
| 68 | Cellulitis (HP:0100658) | 2.51171575 |
| 69 | Aplasia of the musculature (HP:0100854) | 2.50051086 |
| 70 | Gowers sign (HP:0003391) | 2.49094572 |
| 71 | Recurrent bronchitis (HP:0002837) | 2.47803735 |
| 72 | Abnormality of glycolysis (HP:0004366) | 2.44040840 |
| 73 | Increased serum pyruvate (HP:0003542) | 2.44040840 |
| 74 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.44024509 |
| 75 | Rimmed vacuoles (HP:0003805) | 2.43674447 |
| 76 | Pheochromocytoma (HP:0002666) | 2.42873402 |
| 77 | Neuroendocrine neoplasm (HP:0100634) | 2.38354529 |
| 78 | Increased variability in muscle fiber diameter (HP:0003557) | 2.36227713 |
| 79 | Restrictive lung disease (HP:0002091) | 2.35885875 |
| 80 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.35745074 |
| 81 | Acute necrotizing encephalopathy (HP:0006965) | 2.31687484 |
| 82 | Lymphopenia (HP:0001888) | 2.25351334 |
| 83 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.24399249 |
| 84 | Hypoplastic ischia (HP:0003175) | 2.22405980 |
| 85 | Colitis (HP:0002583) | 2.22045346 |
| 86 | Increased connective tissue (HP:0009025) | 2.21382341 |
| 87 | Abnormality of the foot musculature (HP:0001436) | 2.20863633 |
| 88 | Facial diplegia (HP:0001349) | 2.19693770 |
| 89 | Limb-girdle muscle atrophy (HP:0003797) | 2.17995446 |
| 90 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.15340808 |
| 91 | Metatarsus adductus (HP:0001840) | 2.14060118 |
| 92 | Bundle branch block (HP:0011710) | 2.12753254 |
| 93 | Abnormality of the corticospinal tract (HP:0002492) | 2.10475196 |
| 94 | Left ventricular hypertrophy (HP:0001712) | 2.09234793 |
| 95 | Heart block (HP:0012722) | 2.09211577 |
| 96 | Hyperkalemia (HP:0002153) | 2.08425953 |
| 97 | Generalized muscle weakness (HP:0003324) | 2.07450456 |
| 98 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.07237139 |
| 99 | Long clavicles (HP:0000890) | 2.07070646 |
| 100 | Foot dorsiflexor weakness (HP:0009027) | 2.06701466 |
| 101 | Mitochondrial inheritance (HP:0001427) | 2.04126376 |
| 102 | Chronic sinusitis (HP:0011109) | 2.03962364 |
| 103 | Premature skin wrinkling (HP:0100678) | 2.02542413 |
| 104 | Cerebral hemorrhage (HP:0001342) | 2.01941869 |
| 105 | Progressive macrocephaly (HP:0004481) | 2.00834358 |
| 106 | Abnormal EKG (HP:0003115) | 1.99474727 |
| 107 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.97831161 |
| 108 | Steppage gait (HP:0003376) | 1.97396137 |
| 109 | Atrioventricular block (HP:0001678) | 1.96876446 |
| 110 | Recurrent pneumonia (HP:0006532) | 1.96413319 |
| 111 | Palpitations (HP:0001962) | 1.96038656 |
| 112 | Double outlet right ventricle (HP:0001719) | 1.95907971 |
| 113 | Congenital malformation of the right heart (HP:0011723) | 1.95907971 |
| 114 | Distal lower limb amyotrophy (HP:0008944) | 1.94305562 |
| 115 | Leukodystrophy (HP:0002415) | 1.93435088 |
| 116 | Slender build (HP:0001533) | 1.92974670 |
| 117 | Muscular dystrophy (HP:0003560) | 1.92898358 |
| 118 | Nonprogressive disorder (HP:0003680) | 1.92429921 |
| 119 | Akinesia (HP:0002304) | 1.91288336 |
| 120 | Progressive muscle weakness (HP:0003323) | 1.90472238 |
| 121 | EMG: neuropathic changes (HP:0003445) | 1.89269928 |
| 122 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.88727975 |
| 123 | Proximal amyotrophy (HP:0007126) | 1.88168054 |
| 124 | Easy fatigability (HP:0003388) | 1.87859589 |
| 125 | Increased CSF lactate (HP:0002490) | 1.86789527 |
| 126 | Abnormality of the ischium (HP:0003174) | 1.86330055 |
| 127 | Hepatocellular necrosis (HP:0001404) | 1.85801414 |
| 128 | Recurrent lower respiratory tract infections (HP:0002783) | 1.84629198 |
| 129 | Peripheral hypomyelination (HP:0007182) | 1.84067889 |
| 130 | Waddling gait (HP:0002515) | 1.83499668 |
| 131 | Abnormal atrioventricular conduction (HP:0005150) | 1.82696300 |
| 132 | Abnormality of the tricuspid valve (HP:0001702) | 1.82217427 |
| 133 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.80545300 |
| 134 | Absent epiphyses (HP:0010577) | 1.80545300 |
| 135 | Breech presentation (HP:0001623) | 1.79694497 |
| 136 | IgA deficiency (HP:0002720) | 1.79301044 |
| 137 | Malignant hyperthermia (HP:0002047) | 1.76971460 |
| 138 | Atonic seizures (HP:0010819) | 1.76600887 |
| 139 | Difficulty climbing stairs (HP:0003551) | 1.75930757 |
| 140 | Spinal rigidity (HP:0003306) | 1.70438611 |
| 141 | Limited hip movement (HP:0008800) | 1.70084106 |
| 142 | Thin ribs (HP:0000883) | 1.63483127 |
| 143 | Ulnar deviation of finger (HP:0009465) | 1.61009552 |
| 144 | Exercise intolerance (HP:0003546) | 1.58707218 |
| 145 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.53421523 |
| 146 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.50275440 |
| 147 | Lower limb amyotrophy (HP:0007210) | 1.46615136 |
| 148 | Pterygium (HP:0001059) | 1.44343814 |
| 149 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.42279146 |
| 150 | Adducted thumb (HP:0001181) | 1.41991645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.44436664 |
| 2 | STK39 | 3.73255242 |
| 3 | MAP4K1 | 3.48363987 |
| 4 | TTN | 3.38662463 |
| 5 | PHKG2 | 2.94076975 |
| 6 | PHKG1 | 2.94076975 |
| 7 | PKN1 | 2.61662177 |
| 8 | TNIK | 2.48503680 |
| 9 | PINK1 | 2.47088553 |
| 10 | EPHB1 | 2.34871265 |
| 11 | OXSR1 | 2.12532936 |
| 12 | MAPKAPK3 | 2.05153038 |
| 13 | CSF1R | 1.89872054 |
| 14 | PRPF4B | 1.88161397 |
| 15 | DMPK | 1.83484987 |
| 16 | PIK3CA | 1.79730884 |
| 17 | FES | 1.77929682 |
| 18 | MYLK | 1.73958903 |
| 19 | PRKCQ | 1.67653174 |
| 20 | MUSK | 1.67209600 |
| 21 | CLK1 | 1.61041650 |
| 22 | WNK1 | 1.51109169 |
| 23 | CDC42BPA | 1.49947718 |
| 24 | MAP3K13 | 1.49571536 |
| 25 | PRKCH | 1.43944303 |
| 26 | ROCK2 | 1.39812887 |
| 27 | PIK3CG | 1.37237221 |
| 28 | MAP2K6 | 1.32504773 |
| 29 | MAPK12 | 1.30721574 |
| 30 | SYK | 1.26103332 |
| 31 | PRKD1 | 1.22188281 |
| 32 | BLK | 1.19537643 |
| 33 | UHMK1 | 1.19503457 |
| 34 | BTK | 1.19022133 |
| 35 | MARK1 | 1.17580565 |
| 36 | WNK4 | 1.15986463 |
| 37 | CSK | 1.13971997 |
| 38 | CCNB1 | 1.13652845 |
| 39 | EEF2K | 1.13020972 |
| 40 | ICK | 1.10198895 |
| 41 | PBK | 1.09910154 |
| 42 | PAK3 | 1.08412606 |
| 43 | STK24 | 1.05684119 |
| 44 | ROCK1 | 1.04874131 |
| 45 | LYN | 1.03129429 |
| 46 | CAMK2D | 1.02985925 |
| 47 | BCR | 1.02422567 |
| 48 | NME1 | 1.01248081 |
| 49 | FRK | 0.99299890 |
| 50 | TYRO3 | 0.99038251 |
| 51 | FGFR2 | 0.97266079 |
| 52 | MAP3K10 | 0.91869218 |
| 53 | CAMK2G | 0.89702826 |
| 54 | MAP2K4 | 0.89247572 |
| 55 | BRD4 | 0.88901643 |
| 56 | MOS | 0.87280507 |
| 57 | PRKAA1 | 0.87078287 |
| 58 | MAP3K7 | 0.86077335 |
| 59 | MAPK15 | 0.84613474 |
| 60 | STK4 | 0.84472936 |
| 61 | DAPK2 | 0.81444398 |
| 62 | MAPK7 | 0.81189117 |
| 63 | BCKDK | 0.80375907 |
| 64 | IRAK4 | 0.78714828 |
| 65 | GRK7 | 0.75809899 |
| 66 | LIMK1 | 0.74026086 |
| 67 | PDK1 | 0.73525025 |
| 68 | IRAK2 | 0.73038833 |
| 69 | INSRR | 0.72676904 |
| 70 | ITK | 0.69500693 |
| 71 | PDPK1 | 0.68263090 |
| 72 | FGR | 0.67939369 |
| 73 | CSNK1G3 | 0.67889524 |
| 74 | CSNK1A1L | 0.67347786 |
| 75 | FYN | 0.64266718 |
| 76 | MAPK13 | 0.63882898 |
| 77 | MST4 | 0.62941947 |
| 78 | GRK6 | 0.62043224 |
| 79 | CAMK1 | 0.61979364 |
| 80 | LMTK2 | 0.61646980 |
| 81 | TRIB3 | 0.60711525 |
| 82 | MAPK11 | 0.60187134 |
| 83 | TIE1 | 0.59858248 |
| 84 | MAP2K1 | 0.58816918 |
| 85 | TLK1 | 0.58628606 |
| 86 | PRKG1 | 0.58100093 |
| 87 | NEK6 | 0.57752141 |
| 88 | HCK | 0.57513038 |
| 89 | AKT2 | 0.57140545 |
| 90 | MAP4K2 | 0.57067632 |
| 91 | STK10 | 0.56934074 |
| 92 | INSR | 0.56661568 |
| 93 | CAMK4 | 0.56013259 |
| 94 | SGK223 | 0.55621253 |
| 95 | SGK494 | 0.55621253 |
| 96 | PRKCE | 0.55014912 |
| 97 | DYRK1B | 0.54396216 |
| 98 | NEK1 | 0.53132606 |
| 99 | EPHA4 | 0.52798323 |
| 100 | GRK1 | 0.50820334 |
| 101 | TNK2 | 0.49389312 |
| 102 | MARK3 | 0.49180821 |
| 103 | JAK1 | 0.49127038 |
| 104 | LRRK2 | 0.47272932 |
| 105 | CAMK2B | 0.47176255 |
| 106 | PAK6 | 0.46572635 |
| 107 | CSNK1D | 0.46098240 |
| 108 | IRAK1 | 0.45992097 |
| 109 | NEK9 | 0.45557943 |
| 110 | ERN1 | 0.44835478 |
| 111 | RIPK4 | 0.44208668 |
| 112 | PRKAA2 | 0.43993300 |
| 113 | PRKD2 | 0.43897804 |
| 114 | LCK | 0.43689240 |
| 115 | PKN2 | 0.43643213 |
| 116 | ERBB3 | 0.43544455 |
| 117 | ZAK | 0.43327262 |
| 118 | ADRBK2 | 0.43289651 |
| 119 | CSNK1G1 | 0.43096482 |
| 120 | MARK2 | 0.42595836 |
| 121 | MET | 0.40748240 |
| 122 | PDK2 | 0.40597198 |
| 123 | CAMK2A | 0.40361398 |
| 124 | PRKACB | 0.40240499 |
| 125 | PTK2B | 0.39586324 |
| 126 | SIK1 | 0.38504002 |
| 127 | PDK4 | 0.38241674 |
| 128 | PDK3 | 0.38241674 |
| 129 | PRKACA | 0.38074110 |
| 130 | TRPM7 | 0.37010783 |
| 131 | MAPK4 | 0.36941724 |
| 132 | MELK | 0.36516372 |
| 133 | ILK | 0.35475846 |
| 134 | PRKD3 | 0.34890353 |
| 135 | MAP2K3 | 0.34472050 |
| 136 | RPS6KA3 | 0.31861711 |
| 137 | SGK1 | 0.28681452 |
| 138 | STK11 | 0.24063982 |
| 139 | NTRK3 | 0.23500255 |
| 140 | MAPK10 | 0.21841315 |
| 141 | WNK3 | 0.21106459 |
| 142 | TBK1 | 0.19680561 |
| 143 | PRKACG | 0.18683239 |
| 144 | RPS6KA6 | 0.17791133 |
| 145 | MAPKAPK5 | 0.17263984 |
| 146 | BMPR1B | 0.17029974 |
| 147 | DAPK3 | 0.16936188 |
| 148 | RPS6KB1 | 0.16902016 |
| 149 | ADRBK1 | 0.15479544 |
| 150 | SIK2 | 0.15361721 |
| 151 | MAPK8 | 0.14886181 |
| 152 | RPS6KA1 | 0.14002817 |
| 153 | PRKCA | 0.11170185 |
| 154 | SGK3 | 0.10665190 |
| 155 | RPS6KL1 | 0.09453843 |
| 156 | RPS6KC1 | 0.09453843 |
| 157 | PRKCI | 0.09423994 |
| 158 | SGK2 | 0.08334374 |
| 159 | MAPK9 | 0.07578196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.06725760 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.61377595 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.48784022 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.24510682 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.18069177 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.16187501 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.03757641 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.91731578 |
| 9 | Circadian rhythm_Homo sapiens_hsa04710 | 2.66182334 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.56070451 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.45423377 |
| 12 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.18940571 |
| 13 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.09806123 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.98878975 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.90520099 |
| 16 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.85102252 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.81345162 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.79567357 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.77533872 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.73889792 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.71210620 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54340070 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53361654 |
| 24 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.53106156 |
| 25 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.52106441 |
| 26 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.50792278 |
| 27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.46836910 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.45629610 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.43997659 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.42406567 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.29637744 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.28336688 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.24364021 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.23045666 |
| 35 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.21278548 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19237263 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14373489 |
| 38 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.10984097 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.09176126 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.07348966 |
| 41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.06669686 |
| 42 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.05754771 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01496833 |
| 44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.99772204 |
| 45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.96165835 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95916706 |
| 47 | Tight junction_Homo sapiens_hsa04530 | 0.93727670 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93280872 |
| 49 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.93121955 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92173702 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90389231 |
| 52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.89195262 |
| 53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86938147 |
| 54 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.86892044 |
| 55 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.86789356 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85135185 |
| 57 | Morphine addiction_Homo sapiens_hsa05032 | 0.84044013 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.84016943 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83523829 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.82756880 |
| 61 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.82035206 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 0.81132472 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81062185 |
| 64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80160417 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78620903 |
| 66 | Renin secretion_Homo sapiens_hsa04924 | 0.78538375 |
| 67 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78416091 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76902131 |
| 69 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76824634 |
| 70 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76276550 |
| 71 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.76229255 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75954221 |
| 73 | GABAergic synapse_Homo sapiens_hsa04727 | 0.74824854 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73112194 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72898143 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72796261 |
| 77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71888591 |
| 78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.71360164 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71247999 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.68765662 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.68133774 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 0.67775804 |
| 83 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67567192 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66988000 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.66553408 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.66544894 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66076401 |
| 88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63816471 |
| 89 | Peroxisome_Homo sapiens_hsa04146 | 0.63493712 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.63034695 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61764875 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.61743090 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60112332 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59765315 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59451301 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59280060 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58263861 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57320875 |
| 99 | Salivary secretion_Homo sapiens_hsa04970 | 0.56720154 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55600999 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54317056 |
| 102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52756792 |
| 103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51684125 |
| 104 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.51640043 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.50124571 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48877749 |
| 107 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48812064 |
| 108 | Olfactory transduction_Homo sapiens_hsa04740 | 0.48675043 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47540018 |
| 110 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47043081 |
| 111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46600611 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45623875 |
| 113 | Taste transduction_Homo sapiens_hsa04742 | 0.43741223 |
| 114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40975242 |
| 115 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39619033 |
| 116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37571289 |
| 117 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37162356 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36423783 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36119623 |
| 120 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.34809298 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34646021 |
| 122 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32437888 |
| 123 | Insulin secretion_Homo sapiens_hsa04911 | 0.32432266 |
| 124 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32237699 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32004837 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29400071 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29398754 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29370989 |
| 129 | Long-term potentiation_Homo sapiens_hsa04720 | 0.28977866 |
| 130 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.28805953 |
| 131 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.28743872 |
| 132 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27985475 |
| 133 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.27203428 |
| 134 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.26986317 |
| 135 | Salmonella infection_Homo sapiens_hsa05132 | 0.26249200 |
| 136 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.26153367 |
| 137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25654124 |
| 138 | Melanogenesis_Homo sapiens_hsa04916 | 0.25348180 |
| 139 | Purine metabolism_Homo sapiens_hsa00230 | 0.24726131 |
| 140 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.24257817 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23367776 |
| 142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23125678 |
| 143 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22651708 |
| 144 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22474340 |
| 145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22014417 |

